Dermatol. praxi. 2014;8(1):17-19

Genital herpes in women

doc.MUDr.Jozef Záhumenský, Ph.D.
Gynekologicko pôrodnícka nemocnica Koch, Bratislava
Gynekologicko porodnická klinika III. LFUK, Praha

Authors summarize recent opinions on epidemiology, symptoms and treatment of genital herpes. Recently incidence of the primary

manifestations of infection in the genital area in young women is increasing. The causative agent is paradoxically more likely to herpes

simplex virus type I, which is classically find in labial herpes. Dangerous is the occurrence of genital herpes during pregnancy, when is

possibility of vertical transmission and infection of the newborn with a severe course. Caesarean section and antiviral prophylaxis can

reduce this risk to a minimum. In conclusion, the authors attach a short case report of repeated incorrect diagnosis of primary genital

herpes in young women.

Keywords: genital herpes, pregnancy, diagnosis, treatment

Published: June 15, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Záhumenský J. Genital herpes in women. Dermatol. praxi. 2014;8(1):17-19.
Download citation

References

  1. Pinninti SG, Kimberlin DW. Maternal and neonatal herpes simplex virus infections. Am J Perinatol 2013; 30(2): 113-119. Go to original source... Go to PubMed...
  2. Pandey JP. Immunoglobulin genes and immunity to herpes simplex virus type 1. J Infect Dis 2012; 206(1): 143-144. Go to original source... Go to PubMed...
  3. Xu FSternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006; 296(8): 964-973. Go to original source... Go to PubMed...
  4. Bernstein DI, Bellamy AR, Hook ER, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis 2013; 56(3): 344-351. Go to original source... Go to PubMed...
  5. Shaw SY, Bhattacharjee P, Isac S, et al. A cross-sectional study of sexually transmitted pathogen prevalence and condom use with commercial and noncommercial sex partners among clients of female sex workers in southern India. Sex Transm Dis 2013; 40(6): 482-489. Go to original source... Go to PubMed...
  6. Hofstetter AM, Rosenthal SL, Stanberry LR. Current thinking on genital herpes. Curr Opin Infect Dis 2014; 27(1): 75-83. Go to original source... Go to PubMed...
  7. Zahumensky J. Holub M, Maxova K, et al. Unrecognized primary genital herpes infection (case report). Prague Med Rep 2008; 109(2-3): 194-199. Go to PubMed...
  8. Holub M, Aster V, Roubalova K, et al. [Guidelines for the diagnosis and treatment of genital herpes in women]. Klin Mikrobiol Infekc Lek 2009; 15(3): 102-106. Go to PubMed...
  9. Holub M, Aster V, Roubalova K, et al. [Recommendations for diagnosis and therapy of genital herpes in women]. Ceska Gynekol 2009; 74(4): 297-302.
  10. Ferenczy MW. Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virus. Curr Pharm Des 2007; 13(19): 1975-1988. Go to original source... Go to PubMed...
  11. Morello CS, Levinson MS, Kraynyak KA, et al. Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 disease. J Virol 2011; 85(7): 3461-3472. Go to original source... Go to PubMed...
  12. Koren A, Tasher D, Stein M, et al. Neonatal herpes simplex virus infections in Israel. Pediatr Infect Dis J 2013; 32(2): 120-123. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.